Pennsylvania · Long-Acting Injectable Buprenorphine
BRIXADI® & SUBLOCADE® Treatment in Pennsylvania
Meet with a DevotedDOc addiction clinician online. If long-acting buprenorphine is right for you, we'll coordinate your treatment so you can receive the injection at a local medical clinic and continue your care through telemedicine.
Compare BRIXADI & SUBLOCADE
How Long-Acting Buprenorphine Care Works
Five steps, two settings. DevotedDOc provides the medical care and the order; an independent local clinic provides the injection.
Step 01
Meet Online
Complete your addiction-medicine visit with DevotedDOc.
Step 02
Build Your Treatment Plan
Your clinician determines whether injectable buprenorphine is appropriate.
Step 03
Coordinate Medication Access
DevotedDOc sends the prescription or order and clinical documentation. The local clinic generally coordinates insurance authorization and medication acquisition.
Step 04
Receive Your Injection Locally
Travel to an independent medical clinic near you.
Step 05
Continue With DevotedDOc
Continue ongoing OUD treatment and follow-up online.
DevotedDOc provides
The addiction-medicine evaluation, OUD treatment planning, telemedicine visits, the BRIXADI or SUBLOCADE prescription or clinical order, required documentation, and longitudinal follow-up.
Independent injection clinics generally provide
Benefits investigation, prior authorization, medication acquisition, scheduling, the physical injection, injection-site monitoring, and administration confirmation.
Independent injection clinics are separate businesses. They are not owned, controlled, staffed, operated or supervised by DevotedDOc.
Long-Acting Buprenorphine
Treatment in Pennsylvania
Buprenorphine is a medication used to treat opioid use disorder. It reduces cravings and withdrawal and is one of the most established treatments for OUD.
Traditional formulations such as films or tablets are usually taken every day. Extended-release formulations release buprenorphine over a longer period, which removes the daily dosing routine and the need to keep medication at home.
BRIXADI and SUBLOCADE are both extended-release buprenorphine formulations. Both are administered by a healthcare professional rather than self-injected. Whether either one is a good fit depends on your history, your current medication, and your clinical picture — that determination is made by your clinician.
BRIXADI®
Weekly and monthly long-acting buprenorphine options
BRIXADI is given as an injection under the skin on either a weekly or a monthly schedule, which gives your clinician more than one dosing rhythm to work with. It is administered by a healthcare professional at a clinic.
SUBLOCADE®
Monthly extended-release buprenorphine
SUBLOCADE is given as a monthly injection administered by a healthcare professional. One appointment a month covers your buprenorphine dosing for that month.
Find BRIXADI
Injection Access in Pennsylvania
Select a city to see where BRIXADI administration is available. The locations below represent Pennsylvania cities and communities with pharmacies contracted to administer BRIXADI.
Shading reflects counties with BRIXADI administration access through contracted pharmacies. Shaded coverage does not guarantee access at every individual pharmacy location.
44 contracted pharmacies · statewide network
Pennsylvania
BRIXADI injection access through contracted administering pharmacies.
Availability should be confirmed with the administering pharmacy before scheduling.
Coverage and payer requirements vary by pharmacy benefit plan and are verified before an injection appointment is scheduled.
Access verified: September 2026
Source: Braeburn Inc. — Pharmacies Contracted to Administer BRIXADI, September 2026
Pennsylvania Injection Locations
Confirmed injection access, in text. Each confirmed metro links to its local treatment page.
Greater Philadelphia
BRIXADI and SUBLOCADE access
Complete your DevotedDOc appointment online and receive your injection locally through a participating independent pharmacy or healthcare administration site. Multiple locations throughout the Greater Philadelphia area provide long-acting injectable medication administration, including access to BRIXADI and SUBLOCADE.
Contact Us for Injection Site AddressInjection Sites in This Metro
Philadelphia
Philadelphia County — active. Multiple participating administration locations are available throughout the city for long-acting injectable treatment.
Greater Philadelphia
Surrounding Philadelphia communities — active. Additional participating pharmacy and healthcare administration locations are available across the metro area. Availability depends on medication, insurance participation and appointment capacity.
Philadelphia Suburbs
Bucks and Montgomery County areas — coordinated access. DevotedDOc can help identify an appropriate administration location based on where you live and which medication has been prescribed.
Individual pharmacy and administration-site names and street addresses are provided as part of injection coordination. Your DevotedDOc care team gives you the appropriate location and address when your injection appointment is scheduled.
Network expansion markets
DevotedDOc is actively developing local injection access in these Pennsylvania markets. There is no confirmed injection location in them yet, and no clinic marker appears on the map.
Pittsburgh
In development — Western PennsylvaniaHarrisburg
In development — Central PennsylvaniaAllentown / Bethlehem
In development — Lehigh ValleyMarkets under evaluation, with no confirmed access and no announced timeline: Erie, Scranton/Wilkes-Barre, Lancaster, Reading, York and State College.
Greater Philadelphia is DevotedDOc's current Pennsylvania injection access cluster
Participating independent pharmacy and healthcare administration sites across the Greater Philadelphia area provide local access to long-acting injectable buprenorphine. DevotedDOc manages your evaluation, treatment plan and ongoing follow-up online while the participating Pennsylvania administration site provides the injection.
View Pennsylvania Treatment & Injection OptionsMedications Available
BRIXADI weekly, BRIXADI monthly and SUBLOCADE
Insurance
Coverage varies by health plan and administration site. The receiving pharmacy or healthcare location works with your insurance plan and clinician to verify benefits and determine whether prior authorization is required before your injection is scheduled.
Communities Served
Philadelphia and surrounding Greater Philadelphia communities. The specific administration location is coordinated based on your medication, insurance participation, appointment availability and where you live.
Does Insurance Cover BRIXADI
or SUBLOCADE in Pennsylvania?
Coverage varies by health plan and by injection or administration site. Commercial and Medicare plans may cover extended-release buprenorphine, often with prior authorization or other plan requirements. Benefits are always verified before an injection is scheduled.
How coverage generally works in Pennsylvania. Not a guarantee of coverage or payment.
| Coverage Type | What to Expect |
|---|---|
|
Commercial insurance
|
BRIXADI and SUBLOCADE may be covered under a pharmacy or medical benefit, depending on your plan and the administration site. Prior authorization may be required. Manufacturer copay-savings programs may be available for eligible commercially insured patients; government-program patients are generally excluded. |
|
Medicare & Medicare Advantage
|
Coverage depends on your specific benefits, the medication and how it is billed by the receiving administration site. Benefits, patient cost-sharing and any authorization requirements should be verified before scheduling. |
|
Pennsylvania Medicaid / Medical Assistance
|
Pennsylvania Medical Assistance provides coverage for opioid use disorder medications, including BRIXADI and SUBLOCADE, subject to applicable Preferred Drug List, quantity-limit and prior-authorization requirements. Requirements can vary by benefit pathway and managed care organization, so coverage should be verified for each patient before an injection is scheduled. |
|
Self-pay
|
Cash pricing varies by administration site. Ask for an estimate for both the medication and administration before scheduling. Manufacturer patient-assistance resources may also be available depending on eligibility. |
Medication coverage and administration-site participation are two different things
A medication may be covered by your health plan even when a particular Pennsylvania injection or administration site does not participate with that plan. DevotedDOc and the receiving site verify the applicable access pathway before treatment is scheduled.
If you have Pennsylvania Medicaid / Medical Assistance
BRIXADI or SUBLOCADE may be covered through Pennsylvania Medical Assistance, but not every participating administration site accepts every Medicaid managed care plan or can bill the medication and administration through the same benefit. If you have Pennsylvania Medicaid / Medical Assistance, contact us and we'll help you understand your options and identify an available administration pathway when possible.
Medication coverage through Pennsylvania Medical Assistance does not mean statewide injection access. Injection availability depends on the medication, the participating administration site, your specific health plan and any applicable authorization requirements.
Coverage information is educational and is not a guarantee of benefits, authorization or payment. Plan requirements and administration-site participation can change. Your benefits and applicable access requirements are verified before an injection is scheduled.
Why BRIXADI and SUBLOCADE Are Given by a Healthcare Professional
These are provider-administered medications. They are not dispensed to patients for self-injection, and patients do not take the medication home to administer themselves.
Both products are distributed under special federal requirements. The medication is supplied to an authorized healthcare setting or participating administration site rather than directly to the patient, and a qualified healthcare professional gives the injection.
That is why the Pennsylvania treatment model has two settings. A participating pharmacy, clinic or other authorized healthcare setting handles the physical administration. DevotedDOc maintains the clinical treatment relationship — your evaluation, treatment plan, medication decisions and ongoing follow-up care.
It also means you generally do not have to manage the medication-supply process yourself. Depending on the administration site and insurance pathway, the receiving location may coordinate benefits verification, prior authorization, medication acquisition and injection scheduling before your appointment.
Can I Start Buprenorphine Treatment Online in Pennsylvania?
DevotedDOc's licensed clinicians can evaluate Pennsylvania patients for buprenorphine treatment through secure telehealth visits, consistent with current federal and state requirements.
Start Your Online EvaluationEvaluation
A Pennsylvania-licensed clinician reviews your history, your current medications and your treatment goals.
Treatment plan
You and your clinician decide on an appropriate treatment approach together.
Medication selection
Daily buprenorphine, BRIXADI or SUBLOCADE, based on your clinical needs and available local administration options.
Injection coordination, if appropriate
DevotedDOc sends the necessary prescription or order and clinical documentation to a participating Pennsylvania administration site.
Ongoing follow-up
Telemedicine visits continue between injections to monitor cravings, side effects, medication response and ongoing recovery care.
Can I Switch From Suboxone® or Daily Buprenorphine to an Injection in Pennsylvania?
Many patients already taking daily buprenorphine may be candidates for a long-acting injection. It is one of the most common reasons patients explore BRIXADI or SUBLOCADE treatment with DevotedDOc.
Talk With an Addiction ClinicianBRIXADI and SUBLOCADE have different initiation requirements, including considerations related to your current buprenorphine treatment and clinical history.
Whether and when you stop taking your films or tablets depends on which injection you and your clinician choose and your individualized treatment plan.
The transition depends on several clinical factors — including your current dose, treatment history, other medications and response to buprenorphine.
Your DevotedDOc clinician builds the transition plan with you. We do not provide individualized dosing instructions online, and you should not change or stop your medication without guidance from your treating clinician.
Looking for a Long-Acting Treatment Option for Alcohol Use Disorder in Pennsylvania?
DevotedDOc also provides evaluation and ongoing treatment for alcohol use disorder, including extended-release naltrexone (Vivitrol®) when clinically appropriate.
Like long-acting buprenorphine, Vivitrol is administered by a healthcare professional at a local Pennsylvania administration site, while DevotedDOc can provide the clinical evaluation, treatment planning, and ongoing follow-up through telemedicine.
Pennsylvania BRIXADI & SUBLOCADE FAQs
Medical review & sources
This page is educational and is not a substitute for medical advice, diagnosis or treatment. It does not provide individualized dosing guidance. Talk with a licensed clinician about your own care. If you are in crisis, call 911 or call or text 988.
FDA-approved prescribing information for BRIXADI (buprenorphine extended-release injection) and SUBLOCADE (buprenorphine extended-release injection), including applicable REMS requirements and administration by healthcare professionals.
Pennsylvania Department of Human Services — Pennsylvania Medical Assistance Statewide Preferred Drug List, pharmacy coverage resources, prior-authorization requirements and quantity-limit guidance for opioid use disorder medications, including BRIXADI and SUBLOCADE.
SAMHSA — medications for opioid use disorder, treatment guidance and the national treatment locator.
DEA and HHS — telemedicine prescribing of controlled substances, including current federal telemedicine requirements and temporary flexibilities in effect through December 31, 2026.
Manufacturer prescribing, access and patient-support materials for BRIXADI (Braeburn) and SUBLOCADE (Indivior).
Ready to Explore Long-Acting Buprenorphine?
Start with an online addiction-medicine visit. Your DevotedDOc clinician can help determine whether BRIXADI, SUBLOCADE, daily buprenorphine, or another treatment approach is appropriate for you.